Radiology answers you can trace.

Ask any radiology question. Every claim links to the guideline, paper or licensed case it came from, with its evidence tier shown. Built by clinicians, for the whole imaging team.

£9.99 a month after your 14 day trial. No card needed. Cancel anytime.Already have an account? Sign in
ChatCase SearchReport CritiqueCPD Journal
A MyRadAssistant answer on Fleischner guidance for an 8 mm solid nodule, with numbered citations and the UK BTS difference notedVerification: 24 supported, 1 weak, 0 contradicted. Citations: 13 from 3 sources. Trust: 1 guideline-level source.
Case SearchLICENSED FROM RADIOPAEDIA
Case Search results for hepatocellular carcinoma after TACE, each credited to its Radiopaedia author

Licensed content sources

  • NICE
  • RCR iRefer
  • Radiopaedia
  • BMUS
  • Society of Radiographers
SAME QUESTION, TWO ANSWERS

Same question. Two answers.

We asked both the same question. Both answers are shown word for word. One example, not a benchmark.

THE QUESTIONFleischner 2017 guidelines for an incidental 8 mm solid pulmonary nodule
ChatGPTPro, default model, temporary chat

For an incidentally detected solitary solid pulmonary nodule measuring exactly 8 mm, the 2017 Fleischner Society places it in the 6–8 mm category rather than the ">8 mm" category. RSNA Publications +1

RiskFleischner 2017 recommendation
Low riskCT at 6–12 months, then consider CT at 18–24 months if morphology is suspicious or stability is uncertain.
High riskCT at 6–12 months AND CT at 18–24 months.

If the nodule is larger than 8 mm, management changes to considering CT at ~3 months, PET/CT, tissue sampling, or a combination, guided by morphology and clinical risk. RSNA Publications

A useful exam distinction is therefore:
8 mm → 6–8 mm pathway
9 mm (or >8 mm) → >8 mm pathway

These recommendations apply to incidentally detected nodules in adults, and not to lung cancer screening, immunocompromised patients, or patients with a known primary malignancy. RSNA Publications

MyRadAssistantClinical style
KEY POINTS
  • An 8 mm solid nodule falls in the Fleischner 2017 6–8 mm category, not the >8 mm category. For low-risk patients: CT at 6-12 months, then consider CT at 18-24 months; for high-risk patients: CT at 6-12 months, then CT at 18-24 months 1.
  • In UK practice, BTS guidance, which iRefer follows, treats 8 mm as the threshold for Brock risk assessment. This is a material difference from Fleischner.
  • Check the patient is eligible before applying Fleischner. The guideline does not apply to lung cancer screening, patients younger than 35 years, or patients with a history of primary cancer or immunosuppression. 2
Full answer continues with the size bands, follow up by risk group and matching cases:
MyRadAssistant's licensed Radiopaedia case viewer from the same answer, showing an axial chest CT in lung window, slice 36 of 71
From the same answer: licensed cases with full CT stacks you can scroll through. Case courtesy of Lam Van Le, Radiopaedia.org.
Verification 24 supported · 1 weak · 0 contradictedCitations 13 from 3 sources1 guideline-level source
  • Both placed the 8 mm nodule in the right Fleischner category.
  • Only MyRadAssistant flagged that UK BTS guidance uses 8 mm as the threshold for Brock risk assessment.
  • Only MyRadAssistant returned real licensed cases you can scroll through.

Both answers are each the first run, shown word for word; MyRadAssistant's is shortened to its key points and its case viewer. ChatGPT was used on a Pro plan with default settings in a temporary chat, and its answers can vary between runs. ChatGPT is a trademark of OpenAI. MyRadAssistant is not affiliated with or endorsed by OpenAI.

See the full comparison

Four tools.
One evidence base.

Everything a member gets from day one, in the browser on phone or desktop.

01 · CHAT

Ask anything in radiology

Answers link claim by claim to the guideline, paper or licensed case they came from, with the evidence tier shown.

Key points from a real answer on Fleischner guidance, with numbered citations
02 · CASE SEARCH

Search real cases

Browse licensed Radiopaedia cases with full image stacks, by text or by image.

MRI: hepatocellular carcinomaCoronal CT: hepatocellular carcinomaContrast ultrasound: recurrent hepatocellular carcinoma
Case images: Radiopaedia.org, credited to each author in the app.
03 · REPORT CRITIQUE

Sharpen your reports

Paste or dictate a report. Get a structured critique of completeness, terminology, structure and clarity.

Report Critique flagging that a CTPA report does not state assessment to segmental level or opacification quality
04 · CPD JOURNAL

Keep your learning

Your use is logged automatically as learning evidence, ready to export for ARCP or RCR CPD.

CPD Journal showing time logged and estimated CPD credits
  • Linked. Every claim points to the text it came from.
  • Checked. Each answer is cross-checked against its sources.
  • Tiered. Evidence strength shown on every answer.
  • UK first. NICE, RCR and NHS pathways ranked first.

Three tiers, every answer.

Tier 1
Guidelines · Meta-analyses · RCTs
Highest-quality evidence and direct citation coverage.
Tier 2
Cohort & case-control
Strong observational support, transparent limits.
Tier 3
Case reports · Expert opinion
Clearly labelled, lower confidence.

Every modality.
Every role.
Every report.

Fast answers, cited back to source, for trainees, radiologists, reporting radiographers, sonographers and radiology nurses.

01
For the trainee
Revising for FRCR.
“Perthes disease: key signs on the pelvic radiograph?”
Exam prep at The Radiology Academy 
02
For the radiologist
Revisiting a differential.
“Ring-enhancing lesion: what separates abscess from high-grade glioma?”
03
For the reporting radiographer
Checking a follow-up rule.
“Incidental nodule on a chest film: when does BTS advise CT follow-up?”
04
For the sonographer
Refreshing key signs.
“Acute cholecystitis on ultrasound: key signs and pitfalls?”
05
For the radiology nurse
Checking aftercare guidance.
“Contrast extravasation: what does RCR guidance say about aftercare?”

Different roles, one evidence base.

Built by clinicians.
Made for the whole imaging team.

Dr Yiannis Skarparis
FOUNDER
Dr Yiannis Skarparis
Consultant Interventional Radiologist
FRCR, EBIRFounder of The Radiology AcademyCurates the evidence pipeline
Dr Ben Stenberg
CO-FOUNDER AND CLINICAL SAFETY OFFICER
Dr Ben Stenberg
Consultant Sonographer
Founder of the BMUS AI groupOver 25 years in radiologyLeads new technology implementation
Mr Rory Oliver
FRACTIONAL CTO
Mr Rory Oliver
Fractional CTO for HealthTechs
Behind GPNotebookAI, cloud, cyber and ReactHealthcare grade infrastructure and data security
Mrs Christine Lancaster
UI AND UX CONSULTANT
Mrs Christine Lancaster
Product Designer
Product design across South Africa, the GCC, Switzerland and the USMobile, web and design systems

Regulated,
registered, verified.

Only credentials we currently hold are listed here, each independently verifiable. Anything in progress is deliberately left off.

UKCA conformity mark
UKCA · Class I
UKCA-marked Class I medical device under UK MDR 2002 (Declaration of Conformity v1.0). Retrieval & answer function registered with the MHRA.
MHRA register ↗
NHS DSPT
Standards Met — ODS U9L1B, 2025-26 v8, valid to 30 June 2027.
DSPT register ↗
ICO registered
Registration ZB621582, valid to 3 November 2026.
ICO register ↗
Content licences
Full content licences for the RCR iRefer referral guidelines and Radiopaedia.
Licence on file

FAQ:
Everything about
MyRadAssistant

MyRadAssistant uses retrieval-augmented generation (RAG). Before answering anything, it searches a curated radiology and clinical evidence base for relevant source material, then asks a language model to synthesise an answer using only that retrieved text, with citations linking each claim back to the source. General-purpose assistants like ChatGPT answer any topic from their training data and the public web, and don't grade the evidence. RAG anchors every answer to text we actually have. If we don't have it, the system says so rather than guessing. See the full comparison.

Ready to try it?
Start your free trial.

Cancel anytime